U.S., Nov. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07249606) titled 'Momelotinib Effectiveness in Myelofibrosis' on Nov. 18.
Brief Summary: Observational study aimed at evaluating the use of momelotinib in patients with primary or post polycythemia vera (PV) or post essential thrombocythemia myelofibrosis (post-ET MF) in a real-world setting.
Study Start Date: Jan. 02, 2026
Study Type: OBSERVATIONAL
Condition:
Myelofibrosis (MF)
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
Disclaimer: Curated by HT Syndication....